Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation.
Vallbona-Garcia Antoni, Gustavsson Simon T, Gorgels Theo G M F, Tribble James R, Webers Carroll A B, Smeets Hubert J M et al.
Plasma eNAMPT levels didn't differ between glaucoma patients and controls, nor did supplementation change them. Thus, circulating eNAMPT isn't a direct glaucoma biomarker or short-term nicotinamide response indicator.